Health Related Quality of Life and Residual Symptoms in Prostatic Surgical Treatment at Bethesda Hospital Yogyakarta: a Retrospective Study

Daniel Mahendra Krisna, Hariatmoko Hariatmoko, Rizaldy Taslim Pinzon


Background: The incidence of Prostate Enlargement (PE) has been increasing over the years. The satisfaction towards the treatment result and life quality (QOL) improvement must be the key point of PE treatment. QOL is affected by many conditions, such as age, socioeconomic status, comorbid disease, and type of surgery. The objective of the study was to assess the QOL in PE patients post surgery, to explore the predictor factor, and to assess the satisfaction related to urinary functionality in the Indonesian context.

Methods: A retrospective study was conducted and the subjects were all PE patients who underwent surgical treatment. EQ-5D-5L/EQ-VAS and Index Quality of Life (IQL) were used to assess the patient’s QOL & treatment satisfaction. The subjects were divided into several sub-groups based on age, type of surgery, comorbid condition, type of ward, funding source, histopathological result, and the year of treatment. The collected data wee analyzed using Mann-Whitney test, Kruskal Wallis test, or Chi-square test, Spearman’s rho test and multiple linear regression.

Results: All the 149 subjects were at the average age of 69.09 years . There were no significant statistical differences in QOL between age, comorbid conditions, and histopathology result. Health insurance (HI) was significantly associated with QOL. There were improvements of IQL subjects. The most symptoms remaining was frequency (47.4%).

Conclusions: Life improvement must be the major purpose of PE therapy. The association between HI with QOL suggests that a better HI in developing countries can ensure a better quality of life outcome.


Health-related Quality of Life, prostate enlargement, surgery

Full Text:



Unnikrishnan R, Almassi N, Fareed K. Benign prostatic hyperplasia: Evaluation and medical management in primary care. Cleve Clin J Med. 2017;84(1):53-64.

Groves H, Chang D, Palazzi K, Cohen S, Parsons J. The incidence of acute urinary retention secondary to BPH is increasing among California men. Prostate Cancer and Prostatic Dis. 2013;16(3):260-5.

Badan Pusat Statistik. Angka Harapan Hidup di Indonesia Tahun 2015. BPS 2015 [cited 10 January 2017]. Available from: https:/

Baade PD, Youlden DR, Cramb SM, Dunn J, Gardiner RA. Epidemiology of prostate cancer in the Asia-Pacific region. Prostate Int. 2013; 1(2): 47–58.

Kosilov K, Loparev S, Kuzina I, Kosilova L, Ivanovskaya M, Prokofyeva A. Health-related quality of life’s dependence on socio-economic status and demographic characteristics among men with benign prostatic hyperplasia. Andrologia. 2017;e12982.

Ferreira FT, Daltoé L, Succi G, Cunha F, Ferreira JM, Lorenzetti F, Dambros M. Relation between glycemic levels and low tract urinary symptoms in elderly. Aging Male. 2015 ;18(1):34-7.

Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, et al. U.S. norms for six generic healthrelated quality-of-life indexes from the National Health Measurement Study. Medical Care. 2007;45: 1162–70

Al-Rawashdah SF, Pastore AL, Salhi YA, Fuschi A, Petrozza V, Maurizi A, et al. Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes. World J Urol 2017:2(1):1–7.

Fourcade R. Lacoin F, Rouprêt M, Slama A, Fur CL, Michel E, et al. Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tracts symptoms due to benign protatic hyperplasia. World J Urol. 2012;30(3):419-26.

Castro-Díaz D, Díaz-Cuervo H, Pérez M. Hiperplasia benigna de próstata y su tratamiento: impacto en calidad de vida y function sexual (English vers). Actas Urol Esp. 2013;37(4):233-41.

Milicevic S. The Impact of Benign Prostatic Hyperplasia Surgical Treatment with Turp Method on the Quality of Life. Acta Inform Med. 2011;19(3):142-5.

Hadi N, Aminsharifi A, Sadeghi A, Tourchi A. Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia. Qual Life Res. 2012;22(6):1287-93.

Chie W, Blazeby J, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, et al. Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma. Asia Pac J Clinic Onco. 2016;4(1):1-8.

Alvarado-Bolaños A, Cervantes-Arriaga A, Rodríguez-Violante M, Llorens-Arenas R, Calderón-Fajardo H, Millán-Cepeda R, et al. Convergent validation of EQ-5D-5L in patients with Parkinson’s disease. J Neurol Sci. 2015;358(1-2):53-7.

Van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708-15.

Torz C, Poletajew S, Radziszewski P. A prospective, randomized trial comparing the use of KTP (GreenLight) laser versus electroresection-supplemented laser in the treatment of benign prostatic hyperplasia. Cent European J Urol. 2016;69(4):391-5.

Mahmood SN, Aghaways I. Safety of Overnight Hospitalization after Transurethral Resection of Prostate. OJU. 2016;6(1):1-6.

Khan A. Day care monopolar transurethral resection of prostate: Is it feasible?. Urol Ann. 2014;6(4):334-9.

Castro-Díaz D, Callejo D, Cortés X, Pérez M. Estudio de calidad de vida en pacientes con hiperplasia benigna de próstata en tratamiento con silodisina. Actas Urológicas Españolas. 2014;38(6):361-66.

Jo JK, Kim KS, Nam JW, Choi BY, Moon HS. Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey. Int Neurourol J. 2017;21(2):143-51.


Article Metrics

Abstract view : 372 times
PDF - 267 times

 This Journal indexed by




Creative Commons License
AMJ is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License


View My Stats